RP MANAGEMENT, LLC

other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}
cb

Adviser Profile
As of Date 03/28/2024
Adviser Type - Large advisory firm
Number of Employees 86 14.67%
of those in investment advisory functions 43 38.71%
Registration SEC, Approved, 3/30/2012
AUM* 17,646,826,055 8.76%
of that, discretionary 17,646,826,055 8.76%
Private Fund GAV* 3,086,388,907 -3.49%
Avg Account Size 928,780,319 8.76%
SMA’s No
Private Funds 4
Contact Info 212 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
19B 16B 13B 11B 8B 5B 3B
2015 2016 2017 2018 2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeHedge Fund Count1 GAV$1,469,356,971
Fund TypePrivate Equity Fund Count3 GAV$1,617,031,936

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser CLEARWATER MANAGEMENT CO., INC. Hedge Fund223.7m Liquidity Fund- Private Equity Fund559.3m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV782.9m AUM3.8b #Funds8
Adviser ATLAS MERCHANT CAPITAL LLC Hedge Fund591.7m Liquidity Fund- Private Equity Fund713.9m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV1.3b AUM1.3b #Funds7
Adviser SCHOOLCRAFT CAPITAL LLC Hedge Fund102.9m Liquidity Fund- Private Equity Fund111.9m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV214.8m AUM1.2b #Funds9
Adviser STRATEGIC VALUE BANK PARTNERS LLC Hedge Fund211.5m Liquidity Fund- Private Equity Fund236.5m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV448.0m AUM559.3m #Funds5
Adviser DAKOTA PACIFIC GLOBAL MACRO ADVISERS LP Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV- AUM447.9m #Funds-
Adviser BONAVENTURE CAPITAL, LLC Hedge Fund6.2m Liquidity Fund- Private Equity Fund24.6m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV30.8m AUM430.4m #Funds4
Adviser HIGHLAND CAPITAL MANAGEMENT, L.P. Hedge Fund48.9m Liquidity Fund- Private Equity Fund146.8m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV195.7m AUM126.7m #Funds4
Adviser MELKONIAN CAPITAL MANAGEMENT, LLC Hedge Fund306.5m Liquidity Fund- Private Equity Fund65.7m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV372.2m AUM372.2m #Funds4
Adviser WALNUT GROVE CAPITAL PARTNERS, LP Hedge Fund47.6m Liquidity Fund- Private Equity Fund124.9m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV172.5m AUM172.5m #Funds4
Adviser DIXON MIDLAND COMPANY LLC Hedge Fund63.7m Liquidity Fund- Private Equity Fund20.9m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV84.6m AUM- #Funds4

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck TickerG1110E107 Stock NameBIOHAVEN LTD $ Position$146,737,255 % Position64.00% $ Change44.00% # Change0.00%
Stck Ticker23282W605 Stock NameCYTOKINETICS, INC $ Position$51,764,698 % Position23.00% $ Change-3.00% # Change0.00%
Stck Ticker09058V103 Stock NameBIOCRYST PHARMACEUTICALS INC $ Position$29,230,770 % Position13.00% $ Change23.00% # Change0.00%
Stck Ticker92765F108 Stock NameVIRACTA THERAPEUTICS INC $ Position$851 % Position0.00% $ Change-57.00% # Change0.00%

Brochure Summary

Overview

A. RP Management, LLC (also referred to as “we”, “us”, the “firm” and “RPM”), founded in 2003, is an investment services firm specializing in investment management for its clients. Its clients, including private funds and a public limited company incorporated under the laws of England and Wales (the “Clients”), indirectly own portions of subsidiaries holding royalty interests through their interests in one of two vehicles—(A) Royalty Pharma Investments (“RPI”), an Irish Unit Trust (the “Unit Trust”) or (B) Royalty Pharma Investments 2019 ICAV, an Irish Collective Asset-management Vehicle (the “ICAV”). The principal owners of our firm are Pablo Legorreta and RP MIP Holdings LLC. Investors in our Clients are referred to herein as “Investors”.
B. RPM specializes in advising on investments in royalty interests in marketed and development-stage pharmaceutical, biopharmaceutical, medical and/or healthcare products. C. Our firm tailors our advisory services to the individual needs and specified investment mandates of our Clients. We adhere to the investment strategy set forth in the prospectuses of the Clients and the relevant investment management agreements. D. We do not participate in wrap fee programs. The amount of Client assets that we manage on a discretionary basis, as of December 31, 2023, measured in the same manner as our regulatory assets under management, was approximately $17,646,826,055. We do not manage any Client assets on a non-discretionary basis.